Charles Schwab Investment Management Inc Catalent, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $519 Billion
  • Q2 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Catalent, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,638,825 shares of CTLT stock, worth $98.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,638,825
Previous 1,612,137 1.66%
Holding current value
$98.2 Million
Previous $91 Million 1.26%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$53.58 - $57.02 $1.43 Million - $1.52 Million
26,688 Added 1.66%
1,638,825 $92.2 Million
Q1 2024

May 08, 2024
BUY
$42.56 - $59.82 $2.2 Million - $3.09 Million
51,667 Added 3.31%
1,612,137 $91 Million
Q4 2023

Feb 06, 2024
BUY
$32.18 - $46.57 $777,372 - $1.12 Million
24,157 Added 1.57%
1,560,470 $70.1 Million
Q3 2023

Nov 08, 2023
BUY
$44.2 - $50.2 $22.8 Million - $25.9 Million
516,464 Added 50.64%
1,536,313 $69.9 Million
Q2 2023

Aug 09, 2023
BUY
$31.86 - $67.26 $749,410 - $1.58 Million
23,522 Added 2.36%
1,019,849 $44.2 Million
Q1 2023

May 11, 2023
SELL
$45.44 - $74.26 $6.34 Million - $10.4 Million
-139,533 Reduced 12.28%
996,327 $65.5 Million
Q4 2022

Feb 13, 2023
BUY
$41.39 - $81.0 $4.17 Million - $8.17 Million
100,816 Added 9.74%
1,135,860 $51.1 Million
Q3 2022

Nov 14, 2022
BUY
$72.36 - $113.1 $7.1 Million - $11.1 Million
98,160 Added 10.48%
1,035,044 $74.9 Million
Q2 2022

Aug 15, 2022
BUY
$87.2 - $114.05 $2.2 Million - $2.88 Million
25,223 Added 2.77%
936,884 $101 Million
Q1 2022

May 13, 2022
BUY
$94.19 - $124.49 $6.71 Million - $8.87 Million
71,290 Added 8.48%
911,661 $101 Million
Q4 2021

Feb 11, 2022
BUY
$119.57 - $139.07 $3.18 Million - $3.7 Million
26,619 Added 3.27%
840,371 $108 Million
Q3 2021

Nov 16, 2021
BUY
$109.17 - $142.35 $1.41 Million - $1.84 Million
12,911 Added 1.61%
813,752 $108 Million
Q2 2021

Aug 16, 2021
BUY
$100.34 - $115.69 $2.36 Million - $2.72 Million
23,527 Added 3.03%
800,841 $86.6 Million
Q1 2021

May 17, 2021
SELL
$101.51 - $125.27 $2.82 Million - $3.48 Million
-27,807 Reduced 3.45%
777,314 $81.9 Million
Q4 2020

Feb 16, 2021
BUY
$85.88 - $105.36 $493,638 - $605,609
5,748 Added 0.72%
805,121 $83.8 Million
Q3 2020

Nov 13, 2020
SELL
$72.74 - $92.5 $9.39 Million - $11.9 Million
-129,061 Reduced 13.9%
799,373 $68.5 Million
Q2 2020

Aug 14, 2020
SELL
$48.02 - $79.04 $242,789 - $399,626
-5,056 Reduced 0.54%
928,434 $68.1 Million
Q1 2020

May 15, 2020
BUY
$36.95 - $62.95 $2.56 Million - $4.36 Million
69,219 Added 8.01%
933,490 $48.5 Million
Q4 2019

Feb 07, 2020
BUY
$47.06 - $56.64 $202,075 - $243,212
4,294 Added 0.5%
864,271 $48.7 Million
Q3 2019

Nov 08, 2019
SELL
$47.45 - $58.05 $9.05 Million - $11.1 Million
-190,796 Reduced 18.16%
859,977 $41 Million
Q2 2019

Aug 09, 2019
BUY
$39.26 - $54.21 $109,928 - $151,788
2,800 Added 0.27%
1,050,773 $57 Million
Q1 2019

May 14, 2019
BUY
$29.84 - $43.92 $2.37 Million - $3.49 Million
79,474 Added 8.21%
1,047,973 $42.5 Million
Q4 2018

Feb 14, 2019
SELL
$29.95 - $46.34 $4.07 Million - $6.3 Million
-136,016 Reduced 12.31%
968,499 $30.2 Million
Q3 2018

Nov 13, 2018
BUY
$40.12 - $45.55 $1.18 Million - $1.34 Million
29,472 Added 2.74%
1,104,515 $50.3 Million
Q2 2018

Aug 08, 2018
SELL
$38.72 - $42.52 $7.14 Million - $7.84 Million
-184,397 Reduced 14.64%
1,075,043 $45 Million
Q1 2018

May 07, 2018
BUY
$39.4 - $47.39 $3.02 Million - $3.63 Million
76,670 Added 6.48%
1,259,440 $51.7 Million
Q4 2017

Jan 17, 2018
BUY
$37.27 - $43.02 $5.08 Million - $5.87 Million
136,353 Added 13.03%
1,182,770 $48.6 Million
Q3 2017

Nov 13, 2017
BUY
$33.75 - $41.67 $35.3 Million - $43.6 Million
1,046,417
1,046,417 $41.8 Million

Others Institutions Holding CTLT

# of Institutions
489
Shares Held
161M
Call Options Held
286K
Put Options Held
1.04M
View Full List

About Catalent, Inc.

CTLT Quotes by TradingView
  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.8B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email